Mipicoledine

DB15075InvestigationalSmall molecule

Mipicoledine is under investigation in clinical trial NCT01048008 (Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced Cancer).

Formula / weight: C₃₅H₄₈Cl₅NO₄ · 724.02 g/mol (avg)
Also known as: (3.BETA.)-CHOLEST-5-EN-3-YL 3,5-DICHLORO-2-METHOXY-6-(TRICHLOROMETHYL)PYRIDIN-4-YL CARBONATE · 4-demethyl-4-cholesteryloxycarbonylpenclomedine · 4-DEMETHYLCHOLESTERYLOXYCARBONYLPENCLOMEDINE · CHOLEST-5-EN-3-OL (3.BETA.)-, 3-(3,5-DICHLORO-2-METHOXY-6-(TRICHLOROMETHYL)-4-PYRIDINYL CARBONATE) · CHOLEST-5-EN-3.BETA.-YL 3,5-DICHLORO-2-METHOXY-6-(TRICHLOROMETHYL)PYRIDIN-4-YL CARBONATE

Resolves to

Compound

UNII1S83F4T2WECAS942149-56-6ChEMBLCHEMBL4297253

Structure

InChIKeyZJUUIXYKTPSIOH-LEZJFEBPSA-NSMILESCOC1=C(Cl)C(OC(=O)O[C@H]2CC[C@]3(C)[C@H]4CC[C@]5(C)[C@H](CC[C@H]5[C@@H]4CC=C3C2)[C@H](C)CCCC(C)C)=C(Cl)C(=N1)C(Cl)(Cl)Cl

Transporters

P08183ABCB1

What you can answer from here — as of September 19, 2026

1TransporterSubstrate / inhibitor direction, not just membership

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which companies are running trials of Mipicoledine, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account